This study is in progress, not accepting new patients
Study of DNL126 in Pediatric Participants With Mucopolysaccharidosis Type IIIA (Sanfilippo Syndrome Type A)
Summary
- Eligibility
- for people ages 0-18 (full criteria)
- Location
- at Oakland 5378538, California 5332921 and other locations
- Dates
- study startedstudy ends around
Description
Summary
Official Title
Keywords
Eligibility
Locations
Details
- Status
- in progress, not accepting new patients
- Start Date
- Completion Date
- (estimated)
- Sponsor
- Denali Therapeutics Inc.
- ID
- NCT06181136
- Phase
- Phase 1/2 research study
- Study Type
- Interventional
- Participants
- About 20 people participating
- Last Updated